Candriam S.C.A.Candriam S.C.A.

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings711 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.4M$822.1M5.9%$177.01+85.72%
18 qtrssince 2019-Q1
Decreased
0

APPLE INC

3.5M$681.4M4.9%$117.11+63.20%
18 qtrssince 2019-Q1
Decreased
0

MERCK & CO. INC.

3.1M$360.7M2.6%$69.34+51.48%
18 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL A

3M$355.8M2.6%$95.45+23.85%
18 qtrssince 2019-Q1
Decreased
0

THERMO FISHER SCIENTIFIC INC

466,007$243.1M1.8%$417.16+22.37%
18 qtrssince 2019-Q1
Increased
50

UNITEDHEALTH GROUP INC

481,826$231.6M1.7%$364.99+24.52%
18 qtrssince 2019-Q1
Decreased
0

REGENERON PHARMACEUTICALS

305,618$219.6M1.6%$491.40+43.37%
18 qtrssince 2019-Q1
Decreased
0

NVIDIA CORP

499,845$211.4M1.5%$16.57+146.10%
18 qtrssince 2019-Q1
Decreased
0

DANAHER CORP

782,038$187.7M1.4%$175.77+18.39%
18 qtrssince 2019-Q1
Decreased
0

PROCTER & GAMBLE CO/THE

1.1M$170.8M1.2%$111.92+24.50%
18 qtrssince 2019-Q1
Decreased
0

VISA INC-CLASS A SHARES

711,590$169M1.2%$178.21+30.01%
18 qtrssince 2019-Q1
Decreased
0

ELI LILLY & CO

339,317$159.1M1.2%$243.67+88.13%
18 qtrssince 2019-Q1
Decreased
0

AMGEN INC

695,122$154.3M1.1%$177.19+14.27%
18 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

1.2M$151.7M1.1%$105.96+20.71%
18 qtrssince 2019-Q1
Decreased
0

VERTEX PHARMACEUTICALS INC

396,562$139.6M1.0%$206.03+69.00%
18 qtrssince 2019-Q1
Increased
48

JOHNSON & JOHNSON

819,643$135.7M1.0%$139.70+8.81%
18 qtrssince 2019-Q1
Decreased
0

GILEAD SCIENCES INC

1.7M$129.6M0.9%$51.46+35.49%
18 qtrssince 2019-Q1
Increased
43

ADOBE INC

264,568$129.4M0.9%$413.03+18.39%
18 qtrssince 2019-Q1
Decreased
0

MASTERCARD INC - A

314,868$123.8M0.9%$290.13+31.51%
18 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL C

1M$123.5M0.9%$96.54+23.39%
18 qtrssince 2019-Q1
Decreased
0
$13.8B
AUM
711
Positions
Q2 2023
Filing
Rating · 2.5
Quarterly Portfolio Change
-6%Q1'22$14.7B-17%Q2'22$12.1B+17%Q3'22$14.2B+4%Q4'22$14.8B-3%Q1'23$14.4B-4%Q2'23$13.8B
Activity profile
$ moved · Q2'23
New2%Increased27%Decreased60%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 years
<1Q3%1-4Q8%1-2Y7%2Y+82%

Candriam S.C.A. manages $13.8B across 711 positions as of Q2 2023. Top holdings: MSFT (5.9%), AAPL (4.9%), MRK (2.6%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q2 2023 Summary

Active quarter - 31 new positions, 195 exits, 155 increased. Top move: TMO (INCREASED, conviction 50). Portfolio: $13.8B across 711 positions.

Top holdings by portfolio weight

Total AUM$14B
MSFT5.94%
AAPL4.92%
MRK2.61%
GOOGL2.57%
TMO1.76%
UNH1.67%
REGN1.59%
NVDA1.53%
DHR1.36%
PG1.23%
Other1.22%

Portfolio allocation by GICS sector

Sectors11
Healthcare29.42%
Technology28.33%
Financial Services8.10%
Consumer Cyclical7.55%
Industrials7.34%
Communication Services5.39%
Consumer Defensive4.82%
Unknown3.45%
Real Estate1.73%
Utilities1.42%
Other2.45%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record63
Conviction42
Concentration49
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AEMAEMAGNICO EAGLE MINES LTD
Q3 2024 Q2 2026+367,189 shares+$57.7M
8Q
AMZNAMZNAMAZON.COM INC
Q3 2024 Q2 2026+1.1M shares+$328M
8Q
CCCITIGROUP INC
Q3 2024 Q2 2026+275,890 shares+$52.2M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used